Q. What is ZYLEXIS?
A. ZYLEXIS is an inactivated (killed) Parapox Ovis Virus Immunomodulator administered intramuscularly (IM).
Q: What are the indications for ZYLEXIS ?
A: ZYLEXIS is indicated to aid in the reduction of upper respiratory disease associated with EHV 1 & 4 viral infections. This product is indicated for use in horses only.
Q: When do I use it?
A: ZYLEXIS may be administered to horses prior to being subjected to possible stress and during disease episodes. EHV can be easily triggered by common stressors to horses including trailering, competition, breeding and environmental changes.
Q. What is the recommended dose?
A. Dosing consists of one 2 mL IM injection on days 0, 2 & 9. Retreatment is recommended during subsequent disease episodes or prior to stress inducing situations.
Q: Is ZYLEXIS safe?
A: ZYLEXIS has undergone testing in a field safety trial in the US in 333 horses of various breeds ranging in age from 4 months to 20 years. No adverse events were reported8.
Q: How often should I use ZYLEXIS?
A: ZYLEXIS may be administered during subsequent disease episodes or before potentially stress-inducing events such as trailering, competition, breeding, racing or environmental changes.
Q: Can I use ZYLEXIS in foals?
A: Yes. ZYLEXIS is indicated for healthy horses over 4 months of age.